HK1220194A1 - 去氮雜去鐵硫代黴素 類似物的多晶型形式 - Google Patents

去氮雜去鐵硫代黴素 類似物的多晶型形式

Info

Publication number
HK1220194A1
HK1220194A1 HK16108274.2A HK16108274A HK1220194A1 HK 1220194 A1 HK1220194 A1 HK 1220194A1 HK 16108274 A HK16108274 A HK 16108274A HK 1220194 A1 HK1220194 A1 HK 1220194A1
Authority
HK
Hong Kong
Prior art keywords
desazadesferrithiocin
analogs
polymorph forms
polymorph
forms
Prior art date
Application number
HK16108274.2A
Other languages
English (en)
Inventor
TENJARLA Srini
Mcgee Paul
Original Assignee
Ferrokin Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrokin Biosciences Inc filed Critical Ferrokin Biosciences Inc
Publication of HK1220194A1 publication Critical patent/HK1220194A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HK16108274.2A 2013-03-15 2016-07-14 去氮雜去鐵硫代黴素 類似物的多晶型形式 HK1220194A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361789220P 2013-03-15 2013-03-15
PCT/US2014/026365 WO2014143630A1 (en) 2013-03-15 2014-03-13 Polymorph forms of desazadesferrithiocin analogs

Publications (1)

Publication Number Publication Date
HK1220194A1 true HK1220194A1 (zh) 2017-04-28

Family

ID=50514047

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108274.2A HK1220194A1 (zh) 2013-03-15 2016-07-14 去氮雜去鐵硫代黴素 類似物的多晶型形式

Country Status (7)

Country Link
US (1) US9512095B2 (zh)
EP (1) EP2970162A1 (zh)
JP (1) JP2016513652A (zh)
AU (1) AU2014228308A1 (zh)
CA (1) CA2905026A1 (zh)
HK (1) HK1220194A1 (zh)
WO (1) WO2014143630A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2970162A1 (en) 2013-03-15 2016-01-20 Ferrokin Biosciences, Inc. Polymorph forms of desazadesferrithiocin analogs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007012226A (es) 2005-04-04 2007-12-10 Univ Florida Analogos de polieter de desferritiocina.
CN101687825B (zh) 2007-03-15 2014-04-23 佛罗里达大学研究基金公司 去铁硫辛聚醚类似物
KR20110039347A (ko) 2008-07-14 2011-04-15 페로킨 바이오사이언시스 인코포레이티드 금속 킬레이트화제로서의 데스아자데스페리티오신 폴리에테르 유사체의 신규한 염 및 다형체
WO2011017054A2 (en) 2009-07-27 2011-02-10 Ferrokin Biosciences, Inc. Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents
CN103038223A (zh) 2010-05-04 2013-04-10 夏尔有限责任公司 作为金属螯合剂的脱氮杂去铁硫辛类似物
WO2013086312A1 (en) 2011-12-09 2013-06-13 Ferrokin Biosciences, Inc. Oral formulations for treating metal overload
EP2928469A4 (en) 2012-12-07 2016-11-02 Ferrokin Biosciences Inc POLYMORPHIC FORMS OF DESAZADESFERRITHIOCIN ANALOGS
EP2970162A1 (en) 2013-03-15 2016-01-20 Ferrokin Biosciences, Inc. Polymorph forms of desazadesferrithiocin analogs

Also Published As

Publication number Publication date
US9512095B2 (en) 2016-12-06
CA2905026A1 (en) 2014-09-18
US20160024034A1 (en) 2016-01-28
WO2014143630A1 (en) 2014-09-18
JP2016513652A (ja) 2016-05-16
EP2970162A1 (en) 2016-01-20
AU2014228308A1 (en) 2015-08-27

Similar Documents

Publication Publication Date Title
IL269227B (en) Solid forms of treprostinil
HK1222390A1 (zh) 抑制劑的多晶型
GB201421334D0 (en) Synthesis of aeizeolite
HK1216429A1 (zh) 用於純化芳基硫酸酯酶 的方法
HK1214240A1 (zh) 用於製備酰亞胺基二硫酰化合物的方法
GB2516136B (en) Colenterazine analogs
IL281072B (en) Processes for the preparation of pyrimidinylcyclopentane compounds
EP3003320A4 (en) NEW POLYMORPHE OF REGADENOSON
PL3063152T3 (pl) Dogodne wytwarzanie n-podstawionych morfinan-6-oli z morfinan-6-onów
EP3017425C0 (en) IMAGING SYNCHRONIZATION
HRP20182110T1 (hr) Sastav spojeva tiakumicina
HK1220194A1 (zh) 去氮雜去鐵硫代黴素 類似物的多晶型形式
HK1216419A1 (zh) 合成方法
EP2928469A4 (en) POLYMORPHIC FORMS OF DESAZADESFERRITHIOCIN ANALOGS
HK1217700A1 (zh) 多晶型物形式
PL3071575T3 (pl) Wytwarzanie normorfinanów
HK1198422A1 (zh) 羊毛固醇三萜的新穎用途
SG10201701021XA (en) Method of synthesis
GB201310660D0 (en) Synthesis of nucleosides